<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69-antioxidants-09-01191">
 <label>69.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hassannia</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Wiernicki</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ingold</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Qu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Van Herck</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tyurina</surname>
    <given-names>Y.Y.</given-names>
   </name>
   <name>
    <surname>Bayir</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Abhari</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Angeli</surname>
    <given-names>J.P.F.</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>S.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma</article-title>
  <source>J. Clin. Investig.</source>
  <year>2018</year>
  <volume>128</volume>
  <fpage>3341</fpage>
  <lpage>3355</lpage>
  <pub-id pub-id-type="doi">10.1172/JCI99032</pub-id>
  <pub-id pub-id-type="pmid">29939160</pub-id>
 </element-citation>
</ref>
